Carregant...

Direct-acting Anticoagulants in Chronic Coronary Syndromes

Direct-acting oral anticoagulants (DOACs) are easier to use, safer than and as effective as vitamin K antagonists (VKA) in the treatment of non-valvular AF (NVAF). Because of their favourable safety profile and easier use than VKAs, DOACs as anti-thrombotic therapy may have a role in the management...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Cardiol
Autors principals: Sorbets, Emmanuel, Steg, Philippe Gabriel
Format: Artigo
Idioma:Inglês
Publicat: Radcliffe Cardiology 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066807/
https://ncbi.nlm.nih.gov/pubmed/32180831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2018.24.2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!